Literature DB >> 8837393

Effects of the lantibiotic mersacidin on the morphology of staphylococci.

E Molitor1, C Kluczny, H Brötz, G Bierbaum, R Jack, H G Sahl.   

Abstract

Mersacidin is a lanthionine-containing peptide antibiotic (lantibiotic), able to inhibit the growth of a number of Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA) in a manner similar to, but distinct from, vancomycin. In order to further understand the mode of action of this lantibiotic, Staphylococcus simulans 22 cells were treated either with the antibiotics penicillin, tunicamycin or vancomycin or with mersacidin and then compared with untreated cells after electron microscopic examination. Mersacidin treatment brought about a time-dependent, generalised decrease in the thickness of the bacterial cell wall. In addition, mersacidin treatment caused a roughening of the cell wall surface layer and also reduced the thickness and frequency of formation of dividing cell septa. Reduction of cell wall thickness appears to result from inhibition of new wall biosynthesis combined with cell wall turnover. These features of mersacidin-induced effects on cell morphology confirm that it has a novel mode of action (Brötz, H., G. Bierbaum, A. Markus, E. Molitor, and H.-G. Sahl: Antimicrob. Agents Chemother. 39 [1995] 714-719), probably directed towards a membrane-bound biosynthetic step but not towards a specific penicillin-binding-protein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8837393     DOI: 10.1016/s0934-8840(96)80108-3

Source DB:  PubMed          Journal:  Zentralbl Bakteriol        ISSN: 0934-8840


  4 in total

Review 1.  Morphological and ultrastructural changes in bacterial cells as an indicator of antibacterial mechanism of action.

Authors:  T P Tim Cushnie; Noëlle H O'Driscoll; Andrew J Lamb
Journal:  Cell Mol Life Sci       Date:  2016-07-08       Impact factor: 9.261

2.  The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II.

Authors:  H Brötz; G Bierbaum; K Leopold; P E Reynolds; H G Sahl
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

3.  Vancomycin and oritavancin have different modes of action in Enterococcus faecium.

Authors:  Gary J Patti; Sung Joon Kim; Tsyr-Yan Yu; Evelyne Dietrich; Kelly S E Tanaka; Thomas R Parr; Adel Rafai Far; Jacob Schaefer
Journal:  J Mol Biol       Date:  2009-07-01       Impact factor: 5.469

4.  Oritavancin exhibits dual mode of action to inhibit cell-wall biosynthesis in Staphylococcus aureus.

Authors:  Sung Joon Kim; Lynette Cegelski; Dirk Stueber; Manmilan Singh; Evelyne Dietrich; Kelly S E Tanaka; Thomas R Parr; Adel Rafai Far; Jacob Schaefer
Journal:  J Mol Biol       Date:  2008-01-17       Impact factor: 5.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.